Small interfering RNA targeting TNF-α gene significantly attenuates renal ischemia-reperfusion injury in mice

Abstract

Tumor necrosis factor-alpha (TNF-α) has been found to be centrally involved in the development of ischemia-reperfusion injury (IRI)-induced inflammation and apoptosis. Knockdown of TNF-α gene using small interfering RNA (siRNA) may protect renal IRI. Renal IRI was induced in mice by clamping the left renal pedicle for 25 or 35 min. TNF-α siRNA was administered intravenously to silence the expression of TNF-α. The therapeutic effects of siRNA were evaluated in terms of renal function, histological examination, and overall survival following lethal IRI. A single systemic injection of TNF-α siRNA resulted in significant knockdown of TNF-α expression in ischemia-reperfusion injured kidney. In comparison with control mice, levels of BUN and serum creatinine were significantly reduced in mice treated with siRNA. Pathological examination demonstrated that tissue damage caused by IRI was markedly reduced as a result of TNF-α siRNA treatment. Furthermore, survival experiments showed that nearly 90% of control mice died from lethal IRI, whereas more than 50% of siRNApretreated mice survived until the end of the eight-day observation period. We have demonstrated for the first time that silencing TNF-α by specific siRNA can significantly reduce renal IRI and protect mice against lethal kidney ischemia, highlighting the potential for siRNA-based clinical therapy.

Keywords

tumor necrosis factor-alpha / small interfering RNA / ischemia-reperfusion injury / kidney

References

[1] TanakaM, MokhtariGK, TerryRD, et al. . Prolonged cold ischemia in rat cardiac allografts promotes ischemiareperfusion injury and the development of graft coronary artery disease in a linear fashion. J Heart Lung Transplant, 2005, 24(11): 1906-1914 PMID: 16297799

[2] RendersL, HeemannU. Chronic renal allograft damage after transplantation: what are the reasons, what can we do?. Curr Opin Organ Transplant, 2012, 17(6): 634-639 PMID: 23080067

[3] KyllonenLE, SalmelaKT, EklundBH, et al. . Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int, 2000, 13(2): 122-128 PMID: 10836648

[4] DaemenM d, VriesB, BuurmanWA. Apoptosis and inflammation in renal reperfusion injury. Transplantation, 2002, 73(11): 1693-1700 PMID: 12084988

[5] YangFJ, HeYH, ZhouJH. Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury. J Huazhong Univ Sci Technolog Med Sci, 2015, 35(1): 58-63 PMID: 25673194

[6] ZhangJ, LiJH, WangL, et al. . Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(4): 516-520 PMID: 25135720

[7] DonnahooKK, ShamesBD, HarkenAH, et al. . Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol, 1999, 162(1): 196-203 PMID: 10379787

[8] DaemenM v d, VenMW, HeinemanE, et al. . Involvement of endogenous interleukin-10 and tumor necrosis factor-alpha in renal ischemia-reperfusion injury. Transplantation, 1999, 67(6): 792-800 PMID: 10199725

[9] TakadaM, NadeauKC, ShawGD, et al. . The cytokineadhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest, 1997, 99(11): 2682-2690 PMID: 9169498

[10] CrismanJM, RichardsLL, ValachDP, et al. . Chemokine expression in the obstructed kidney. Exp Nephrol, 2001, 9(4): 241-248 PMID: 11423723

[11] TasdemirC, TasdemirS, VardiN, et al. . Protective effect of infliximab onischemia/reperfusion-induced damage in rat kidney. Ren Fail, 2012, 34(9): 1144-1149 PMID: 22950848

[12] MaierS, EmmanuilidisK, EntleutnerM, et al. . Massive chemokine transcription in acute renal failure due to polymicrobial sepsis. Shock, 2000, 14(2): 187-192 PMID: 10947165

[13] EspositoE, MazzonE, MuiaC, et al. . Splanchnic ischemia and reperfusion injury is reduced by genetic or pharmacological inhibition of TNF-alpha. J Leukoc Biol, 2007, 81(4): 1032-1043 PMID: 17210619

[14] SouzaDG, FerreiraFL, FagundesCT, et al. . Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice. Eur J Pharmacol, 2007, 57(1): 72-80

[15] Di PaolaR, GenoveseT, ImpellizzeriD, et al. . The renal injury and inflammation caused by ischemia-reperfusion are reduced by genetic inhibition of TNF-aR1: a comparison with infliximab treatment. Eur J Pharmacol, 2013, 700(1-3): 134-146 PMID: 23291313

[16] ChimTE, LiM, QianH, et al. . RNA interference: a potent tool for gene-specific therapeutics. Am J Transplant, 2004, 4(8): 1227-1236

[17] ZhengX, FengB, ChenG, et al. . Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant, 2006, 6(9): 2099-2108 PMID: 16796725

[18] ZhangX, ZhengX, SunH, et al. . Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation, 2006, 82(12): 1728-1732 PMID: 17198267

[19] YangC, ZhaoT, ZhaoZ, et al. . Serum-stabilized naked caspase-3 siRNA protects autotransplant kidneys in a porcine model. Mol Ther, 2014, 22(10): 1817-1828 PMID: 24930602 PMCID: 4428396

[20] HamarP, SongE, KokenyG, et al. . Small interfering RNA targeting Fas protects mice against renal ischemiareperfusion injury. Proc Natl Acad Sci USA, 2004, 101(41): 14883-14888 PMID: 15466709 PMCID: 522049

[21] SingaraveluK, PadanilamBJ. p53 target Siva regulates apoptosis in ischemic kidneys. Am J Physiol Renal Physiol, 2011, 300(5): F1130-1141 PMID: 21307125 PMCID: 3094050

[22] XuY, ArenasIA, ArmstrongSJ, et al. . Estrogen improves cardiac recovery after ischemia/reperfusion by decreasing tumor necrosis factor-alpha. Cardiovasc Res, 2006, 69(4): 836-844 PMID: 16403479